6505--MEMANTINE HCL 10MG TAB - Vendor Here

The contract award pertains to the supply of MEMANTINE HCL 10MG TAB 60CT, with a total awarded value of $23,378.52, under solicitation number 36C77026Q0125, issued by the Department of Veterans Affairs through the National CMOP Office in Leavenworth, Kansas. This is a firm-fixed-price contract awarded as a total small business set-aside under FAR 19.5, with the NAICS code 325412, indicating pharmaceutical preparation manufacturing, and the size standard is 1,300 employees. The delivery is to be made to the VA CMOP facility in Tucson, Arizona, under FOB destination terms, with full risk transfer occurring upon arrival. The contractor must deliver 11,748 bottles within 10 days of receipt of order, adhering to strict packaging and labeling requirements including child-safety caps, cylindrical bottle dimensions, and GS1-128 or HIBCC-compliant barcoding at the unit-of-use level with minimum ANSI/ISO/IEC Grade C quality. Each shipment must include a detailed packing slip referencing the VA purchase order, obligation number, NDC, and vendor contact, and must be coordinated during CMOP facility operational hours. Products must be shippable via USPS, non-flammable, and expire no sooner than 12 months after delivery, with no more than three lot numbers per shipment unless approved. The contract incorporates multiple FAR clauses with deviations, including whistleblower protections, prohibitions on internal confidentiality agreements, contractor employee rights, and specific requirements around trafficking, child labor, sustainable products, and the Buy American Act—all marked with "(DEVIATION)" to denote modified text. Offerors were required to submit electronic representations including a unique entity ID, small business self-certification, a valid state wholesale distributor license, and a Buy American Act Certificate. Invoicing must be electronic under VAAR 852.232-72 and conform to the Prompt Payment Act, with payment via Electronic Funds Transfer to the VA’s designated payment office in Leavenworth. The award will be based on a trade-off evaluation of past performance and price, with no specified weights or adjectival ratings, meaning the government may select the most advantageous offer beyond the lowest price. Special contractual obligations include indemnification against patent infringement, compliance with DSCSA for drug supply chain security, and adherence to multiple federal statutes